Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules

A novel polyelectrolyte nanocapsule system composed of biopolymers, chitosan and heparin has been fabricated by the layer-by-layer technique on silica nanoparticles followed by dissolution of the silica core. The nanocapsules were of the size range 200 ± 20 nm and loaded with the positively charged anticancer drug doxorubicin with an efficiency of 89%. The loading of the drug into the capsule happens by virtue of the pH-responsive property of the capsule wall, which is determined by the pKa of the polyelectrolytes. As the pH is varied, about 64% of the drug is released in acidic pH while 77% is released in neutral pH. The biocompatibility, efficiency of drug loading, and enhanced bioavailability of the capsule system was confirmed by MTT assay and in vivo biodistribution studies.

[1]  T. Hwang,et al.  The synthesis of poly(vinylphosphonic acid-co-methacrylic acid) microbeads by suspension polymerization and the characterization of their indium adsorption properties. , 2012, Journal of Hazardous Materials.

[2]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[3]  S. Choe,et al.  Control of molecular weight of polystyrene using the reverse iodine transfer polymerization (RITP)-emulsion technique. , 2011, Journal of colloid and interface science.

[4]  A. Maitra,et al.  Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[5]  Michiya Matsusaki,et al.  Enzyme-responsive release of encapsulated proteins from biodegradable hollow capsules. , 2006, Biomacromolecules.

[6]  Xiaoling Yang,et al.  (PAH/PSS)5 microcapsules templated on silica core: Encapsulation of anticancer drug DOX and controlled release study , 2005 .

[7]  Miqin Zhang,et al.  Chitosan-alginate hybrid scaffolds for bone tissue engineering. , 2005, Biomaterials.

[8]  K. Luk,et al.  An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. , 2005, Biomaterials.

[9]  C. Massart,et al.  Doxorubicin induces Fas-mediated apoptosis in human thyroid carcinoma cells. , 2004, Thyroid : official journal of the American Thyroid Association.

[10]  Lie Ma,et al.  Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. , 2003, Biomaterials.

[11]  K. Janes,et al.  Polysaccharide colloidal particles as delivery systems for macromolecules. , 2001, Advanced drug delivery reviews.

[12]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[13]  C. Cho,et al.  Association of heparin with basic fibroblast growth factor, epidermal growth factor, and constitutive nitric oxide synthase on healing of gastric ulcer in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[14]  Caruso,et al.  Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating , 1998, Science.

[15]  Helmuth Möhwald,et al.  Novel Hollow Polymer Shells by Colloid-Templated Assembly of Polyelectrolytes. , 1998, Angewandte Chemie.

[16]  Gleb B. Sukhorukov,et al.  LAYER-BY-LAYER SELF ASSEMBLY OF POLYELECTROLYTES ON COLLOIDAL PARTICLES , 1998 .

[17]  K. C. Kwan.  Oral bioavailability and first-pass effects. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[18]  H. Kaş.  Chitosan: properties, preparations and application to microparticulate systems. , 1997, Journal of microencapsulation.

[19]  Gero Decher,et al.  Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites , 1997 .

[20]  D. Gewirtz,et al.  Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. , 1994, Molecular pharmacology.

[21]  S. Lin,et al.  The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex. , 1985, Chemical & pharmaceutical bulletin.

[22]  Javier Rojo,et al.  Synthetic Strategies to Create Dendrimers: Advantages and Drawbacks , 2012 .

[23]  Robert Gurny,et al.  Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  C. Yomota,et al.  [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate]. , 1990, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences.

[25]  A. Meshorer,et al.  Reduced toxicity of daunorubicin by conjugation to dextran. , 1982, Cancer treatment reports.

[26]  E. A. Johnson,et al.  Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. , 1979, Thrombosis research.